Clomiphene's First Trial Showed It Could Trigger Ovulation
This 1961 study tested a new drug, chloramiphene (now called clomiphene), in 36 women with amenorrhea who were not ovulating. 28 of the 36 women began ovulating after treatment. Doctors confirmed ovulation with temperature charts, tissue tests, and symptom timing.
Key Findings
The study included 36 women with functional or secondary amenorrhea who were not having ovulatory cycles.
28 of the 36 women developed ovulatory menstrual cycles after treatment, based on a sustained temperature shift, biopsy-confirmed secretory endometrium, and premenstrual symptoms.
The temperature shift that signals ovulation lasted 14 to 21 days in treated women, which the paper describes as longer than the usual 14-day luteal phase.
Hot flashes were common during treatment, and a persistent corpus luteum cyst sometimes occurred, more often with prolonged treatment.
The paper reported no comparison group and did not report whether any of the women became pregnant.
Interpretation
This case series took place at one center in 1961, following 36 women with amenorrhea who were not ovulating. Doctors treated them with chloramiphene. Most of the women, 28 of 36, began ovulating after treatment. Doctors confirmed this with temperature charts, endometrial biopsy, and symptom timing. The findings support larger studies of this drug as a treatment for a lack of ovulation.
RRM Context
This 1961 report introduced a drug later sold as clomiphene citrate. Doctors still prescribe it today to trigger ovulation in women who are not ovulating on their own. Restorative reproductive medicine treats the root cause of infertility, including a lack of ovulation. IVF programs use related drugs for a different goal. They aim to produce many eggs for a lab procedure. Restorative reproductive medicine aims instead to restore a woman's own cycle.
Our editorial summary of this paper, not the article's abstract.